Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

S. Korea FDA Warns Against Cold Medicines For Children Under 2

This article was originally published in PharmAsia News

Executive Summary

Korea's Food and Drug Administration warned physicians and the public against giving over-the-counter cold medicines to children under two years old. The warning also said giving children two kinds of antihistamine cold pills at the same time could be fatal. The agency stopped short of banning fever medicines such as ibuprofen and acetaminophen, but urged drug makers to put warnings on their labels to provide notice of the dangers of not following recommended dosages for children under two. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066737

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel